Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-007396

President and CEO sold 50,000 shares at $45.97 ($2,298,650)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-06 Exercise or conversion : show line 1 in the form +50,000 $14.66 $733,000 587,160 D
2021-07-06 Sale : show line 2 in the form −50,000 $45.97 $2,298,650 537,160 D
Open-market sales · 50,000 sh · avg $45.97 · $2,298,650

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2021-07-06 Exercise or conversion : show line 3 in the form Option to Purchase Common Stock −50,000 $14.66 $733,000 $14.66 2024-01-06 50,000 350,000 D
Loading xslF345X03/edgar.xml…